SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,040.98 -82.85
( -0.11%)

Global Indices

Nasdaq

52,230.09 -658.89
(-1.25%)

Dow Jones

7,644.13 -40.30
(-0.52%)

Hang Seng

62,584.98 -322.86
(-0.51%)

Nikkei 225

10,670.63 -54.40
(-0.51%)

Forex

USD-INR

94.61 0.10
(0.11%)

EUR-INR

106.18 0.08
(0.07%)

GBP-INR

126.70 0.19
(0.15%)

JPY-INR

0.60 0.00
(0.70%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Marksans Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524404

INE750C01026

36.4616629

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MARKSANS

40.39

12994.47

EPS(TTM)

Face Value()

Div & Yield %

7.1

0.31

Back

SEPC reports consolidated net loss of Rs 11.05 crore in the June 2026 quarter

Aug 12,2026

Net loss of SEPC reported to Rs 11.05 crore in the quarter ended June 2026 as against net profit of Rs 16.55 crore during the previous quarter ended June 2025. Sales rose 35.36% to Rs 273.80 crore in the quarter ended June 2026 as against Rs 202.28 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	273.80	202.28	35
OPM %	6.30	13.96	-
PBDT	14.46	20.27	-29
PBT	13.17	19.05	-31
NP	-11.05	16.55	PL

73,040.98 -82.85 ( -0.11%)

52,230.09 -658.89 (-1.25%)

7,644.13 -40.30 (-0.52%)

62,584.98 -322.86 (-0.51%)

10,670.63 -54.40 (-0.51%)

94.61 0.10 (0.11%)

106.18 0.08 (0.07%)

126.70 0.19 (0.15%)

0.60 0.00 (0.70%)